These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7432210)

  • 21. Influenza antibody response following aerosal administration of inactivated virus.
    Waldman RH; Wood SH; Torres EJ; Small PA
    Am J Epidemiol; 1970 Jun; 91(6):574-85. PubMed ID: 5445644
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibody response to inactivated subunit influenza vaccine in patients with Wegener's granulomatosis.
    Zycinska K; Romanowska M; Nowak I; Rybicka K; Wardyn KA; Brydak LB
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):819-28. PubMed ID: 18204196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection.
    Sylte MJ; Hubby B; Suarez DL
    Vaccine; 2007 May; 25(19):3763-72. PubMed ID: 17350145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C; Megas F; Piercy J
    Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-neuraminidase antibody response after administration of a split influenza vaccine.
    Constantinescu C; Ioniţă E; Alexandrescu V; Maţepiuc M; Creţescu L; Niculescu IT
    Arch Roum Pathol Exp Microbiol; 1985; 44(1):37-41. PubMed ID: 4038049
    [No Abstract]   [Full Text] [Related]  

  • 26. [Role of antineuraminidase antibodies in protection against influenza].
    Aymard M; Gerentes L; Kessler N
    Bull Acad Natl Med; 1998; 182(8):1723-36; discussion 1736-7. PubMed ID: 10188318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-reactive H1N1 antibody responses to a live attenuated influenza vaccine in children: implication for selection of vaccine strains.
    Lee MS; Yang CF
    J Infect Dis; 2003 Nov; 188(9):1362-6. PubMed ID: 14593595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-reactivity of influenza A (H3N2) hemagglutination-inhibition antibodies induced by an inactivated influenza vaccine.
    Kojimahara N; Maeda A; Kase T; Yamaguchi N
    Vaccine; 2006 Aug; 24(33-34):5966-9. PubMed ID: 16777274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmentation of the immune response to influenza vaccine by acetylsalicylic acid: a clinical trial in a geriatric population.
    Hsia J; Tang T; Parrott M; Rogalla K
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):677-83. PubMed ID: 7746030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuraminidase antibodies and H5N1: geographic-dependent influenza epidemiology could determine cross-protection against emerging strains.
    Bermejo-Martin JF; Kelvin DJ; Guan Y; Chen H; Perez-Breña P; Casas I; Arranz E; de Lejarazu RO
    PLoS Med; 2007 Jun; 4(6):e212. PubMed ID: 17593897
    [No Abstract]   [Full Text] [Related]  

  • 33. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients.
    Vogtländer NP; Brown A; Valentijn RM; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 2004 Jun; 22(17-18):2199-201. PubMed ID: 15149777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A field experiment with neuraminidase influenza vaccine (author's transl)].
    Janout V; Uvízl M; Kotíková J; Jukl V
    Cesk Epidemiol Mikrobiol Imunol; 1981 Jul; 30(4):203-12. PubMed ID: 6455206
    [No Abstract]   [Full Text] [Related]  

  • 35. Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects.
    Treanor J; Nolan C; O'Brien D; Burt D; Lowell G; Linden J; Fries L
    Vaccine; 2006 Jan; 24(3):254-62. PubMed ID: 16129526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Staff vaccination with a new subunit influenza vaccine].
    Just M; Moritz A; Schoch J; Lattmann P
    Schweiz Med Wochenschr; 1978 Jan; 108(2):47-52. PubMed ID: 622533
    [No Abstract]   [Full Text] [Related]  

  • 37. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
    Mahmood K; Bright RA; Mytle N; Carter DM; Crevar CJ; Achenbach JE; Heaton PM; Tumpey TM; Ross TM
    Vaccine; 2008 Oct; 26(42):5393-9. PubMed ID: 18706956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence vaccination: comparison of the effectiveness of two different vaccines].
    Kuwert E; Thraenhart O; Werner J; Höher PG
    Med Klin; 1980 Oct; 75(21):755-8. PubMed ID: 7453623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal powder immunization against influenza.
    Dean HJ; Chen D
    Vaccine; 2004 Dec; 23(5):681-6. PubMed ID: 15542190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.